Elevation of plasma aspartylglucosaminidase is a useful marker for the congenital disorders of glycosylation type I (CDG I)
Short Report
- 88 Downloads
- 8 Citations
Summary
Elevated plasma aspartylglucosaminidase activity was found in 21/25 cases of CDG Ia, in single cases of CDG Ib, Ic and If, and in 15/16 cases of CDG Ix. The CDG I patients in whom the activity was not raised were either atypical clinically (CDG Ia) or very young (CDG Ih).
Keywords
Public Health Internal Medicine Congenital Disorder Metabolic Disease Single Case
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- Clayton P, Winchester B, di Tomaso M, Young E, Keir G, Rodeck C (1993) Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus. Lancet 341: 956.PubMedGoogle Scholar
- Jaeken J (2003) Congenital disorders of glycosylation (CDG): Its all in it! J Inherit Metab Dis 26: 99–118.PubMedCrossRefGoogle Scholar
- Stibler H, Jaeken J, Kristiansson B (1991) Biochemical characteristics and diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand Suppl 375: 21–31.Google Scholar
Copyright information
© SSIEM and Springer 2005